AlphAIAlphAI — Financial news for AI agents
stocktitan.netOCT 271 min read$PETS

A live webcast will cover PetMeds' results on Nov. 10 at 4:30 p.m. ET

PetMed Express (PETS) will release its Q2 2026 financial results on Nov. 10 after market close and host a conference call at 4:30 p.m. ET. The company is a direct-to-consumer pet healthcare provider, operating online pharmacies PetMeds and PetCareRx.

Original reporting
stocktitan.net
Published Oct 27, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$PETS
Neutral
medium confidence
Mentioned
$PETS
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$PETSNeutralLow
01

Why it matters

The announcement of the earnings webcast date alone offers little actionable insight; price movement will likely await the actual results.

02

Market read

Low relevance; serves as a reminder of an upcoming earnings release with no new financial metrics.

03

What to watch

Potential market anticipation of results, but no concrete data provided.

Relevance 4/10Novelty 3/10Timing: Nov 10, 2026 after market close

Background

PetMed Express (NASDAQ:PETS) is a leading online pet‑health pharmacy. The company is scheduled to release its Q2 2026 earnings on Nov 10.

Company-level read

Ticker impact

$PETSNeutralMedium confidence
Context

PetMed Express announced it will report its Q2 2026 results on Nov 10, 2026.

Expected impact

minimal impact as no guidance or results are disclosed yet

Evidence & confidence

The article only provides the timing of the earnings release; traders have no new data to act on.

Market effects

Sector

None disclosed

Regional

None disclosed

Global

Limited to investors tracking pet‑care sector earnings

Counterpoint

What could challenge this read

No contrarian angle; the notice is purely informational.

Key entities

  • company
    PetMed Express, Inc.

    Online pet pharmacy reporting Q2 2026 earnings

Read at source← All news

Related articles

AUG 20
$PETSMed

PetMed Express (PETS) Q1 2027 Earnings Call Transcript

PetMed Express reported Q1 2027 net sales of $41M, down 19.9% YoY, with a net loss of $6.1M. Key highlights include a $37M sale-leaseback deal, a partnership with Rural King, and an unsolicited acquisition offer of $3 per share. Management emphasized expense management and new revenue channels. Net sales stabilized above $40M sequentially, despite prescription sales declines.

fool.com3 min
AUG 13
$PETSMed

PETMED EXPRESS INC (PETS): PetMeds® Announces First Quarter Financial Results

PETMED EXPRESS INC (PETS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PetMeds® Announces First Quarter Financial Results Delray Beach, Florida, August 13, 2026, PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its first quarter ended June 30, 2026. Quarterly Highl

SEC EDGAR 8-K6 min
JUN 3
$PETSMedAI 9/10

PetMed Express Inc (PETS) Q4 2026 Earnings Call Highlights: Navigating Challenges and Embracing...

PetMed Express (PETS) reported fiscal 2026 net sales down 21.1% and a full-year net loss of $57.3 million, including $26.7 million goodwill impairment and $2.1 million inventory write-down, plus $4.5 million in non-recurring legal/severance costs tied to a whistleblower probe. The company said it regained regulatory compliance, fixed three material weaknesses, exited underperforming vendors for ~$6.1 million annualized savings, and saw its first Q4 sequential net sales increase since 2024.

finance.yahoo.com4 min
OCT 28
$STLAHighAI 8/10

Stellantis rallies on results, but more than one quarter is needed to turn around the business (STLA:NYSE)

Stellantis (STLA) shares rose over 18 months on Q3 results, beating expectations. Cost-cutting boosted adjusted operating income, with a profitable North American segment. Revenue and AOI figures were not disclosed. The company aims to sustain this momentum. According to the company, more than one quarter is needed to turn around the business.

seekingalpha.com1 min
OCT 28
$ORCLHighAI 9/10

Oracle sets FY30 revenue target above $225B with 35% growth rate

Oracle (NYSE:ORCL) set FY30 targets at Investor Day, aiming for $225B+ revenue (35% CAGR), $21+ non-GAAP EPS, and 40%+ operating margin. FY29 free cash flow target is $30B, with capital expenditures declining. Oracle plans $20B in additional capital raises by FY30, excluding refinancing. FY27 outlook reaffirmed: $90B+ revenue, $8.10 non-GAAP EPS.

investing.com2 min